Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

O Ziegler

Showing results (11-20 of 93) with videos related to

Pageof 10
Sort By:
La Revue Du Praticien|May 1, 1992
[Insulin in type 2 diabetes. Why, when, how?]J Simon, O Ziegler, P Drouin
Diabetes & Metabolism|November 7, 1998
[Methodology of the article on "Recommendations for the diagnosis, prevention and the treatment of obesity in France"]M Laville, O Ziegler, A Basdevant
Presse Medicale (Paris, France : 1983)|January 22, 1994
[Hyperlipidemia during diabetes mellitus. Recent developments]B Guerci, O Ziegler, P Drouin
Diabetes & Metabolism|April 27, 2002
Recommendations for the diagnosis, the prevention and the treatment of obesityA Basdevant, M Laville, O Ziegler, et al.
Diabete & Metabolisme|September 1, 1993
[Optic neuropathy in diabetic subjects]M Algan, O Ziegler, P Drouin
Diabete & Metabolisme|November 1, 1992
[Blood glucose self-monitoring in 1993]O Ziegler, B Guerci, P Drouin
La Revue Du Praticien|February 9, 1989
[HMG CoA reductase inhibitors: a new class of hypocholesterolemic agents]O Ziegler, P Drouin, G Debry
Journal Des Maladies Vasculaires|January 1, 1993
[Medical treatment of diabetic arteriopathy]I Got, O Ziegler, P Drouin
Archives Des Maladies Du Coeur Et Des Vaisseaux|December 2, 1998
[The "second atherogenic phenotype" or the role of insulin resistance in vascular risk]O Ziegler, B Guerci, P Drouin
Diabetes & Metabolism|November 7, 1998
[Practice guideline for the diagnosis, prevention, treatment of obesity in France. Groupe de Travail charge de la mise au point des "Recommandations pour le diagnostic, la prévention et le traitement des Obésités en France"]A Basdevant, M Laville, O Ziegler
Pageof 10

Showing results (11-20 of 93) with videos related to

Sort By:
Pageof 10
La Revue Du Praticien|May 1, 1992
[Insulin in type 2 diabetes. Why, when, how?]J Simon, O Ziegler, P Drouin
Diabetes & Metabolism|November 7, 1998
[Methodology of the article on "Recommendations for the diagnosis, prevention and the treatment of obesity in France"]M Laville, O Ziegler, A Basdevant
Presse Medicale (Paris, France : 1983)|January 22, 1994
[Hyperlipidemia during diabetes mellitus. Recent developments]B Guerci, O Ziegler, P Drouin
Diabetes & Metabolism|April 27, 2002
Recommendations for the diagnosis, the prevention and the treatment of obesityA Basdevant, M Laville, O Ziegler, et al.
Diabete & Metabolisme|September 1, 1993
[Optic neuropathy in diabetic subjects]M Algan, O Ziegler, P Drouin
Diabete & Metabolisme|November 1, 1992
[Blood glucose self-monitoring in 1993]O Ziegler, B Guerci, P Drouin
La Revue Du Praticien|February 9, 1989
[HMG CoA reductase inhibitors: a new class of hypocholesterolemic agents]O Ziegler, P Drouin, G Debry
Journal Des Maladies Vasculaires|January 1, 1993
[Medical treatment of diabetic arteriopathy]I Got, O Ziegler, P Drouin
Archives Des Maladies Du Coeur Et Des Vaisseaux|December 2, 1998
[The "second atherogenic phenotype" or the role of insulin resistance in vascular risk]O Ziegler, B Guerci, P Drouin
Diabetes & Metabolism|November 7, 1998
[Practice guideline for the diagnosis, prevention, treatment of obesity in France. Groupe de Travail charge de la mise au point des "Recommandations pour le diagnostic, la prévention et le traitement des Obésités en France"]A Basdevant, M Laville, O Ziegler
Pageof 10